National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 06/26/2008



General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter






Stages of Transitional Cell Cancer of the Renal Pelvis and Ureter







Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter






Treatment Option Overview






Treatment Options for Transitional Cell Cancer of the Renal Pelvis and Ureter






To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter






Get More Information From NCI






Changes to This Summary (06/26/2008)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Questions about cancer?

1-800-4-CANCER
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to the Nation Finds Continued Declines in Cancer Rates
Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter

Recurrent transitional cell cancer of the renal pelvis and ureter is cancer that has recurred (come back) after it has been treated. The cancer may come back in the renal pelvis, ureter, or other parts of the body.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov